| Income Statement | 2024-06-30 | |||
|---|---|---|---|---|
| Net revenue | 27 | |||
| Us-gaap_costofgoodsandserviceexcludingdepreciationdepletionandamortization | 3.831 | |||
| Us-gaap_grossprofit | 23.169 | |||
| General and administrative expenses | 7.379 | |||
| Research, development and medical affairs expenses | 4.263 | |||
| Depreciation and amortization | 3.093 | |||
| Sales and marketing expenses | 8.511 | |||
| Us-gaap_operatingexpenses | 23.246 | |||
| Us-gaap_operatingincomeloss | -0.077 | |||
| Unrealized foreign currency loss, net | -0.125 | |||
| Change in fair value of warrant asset | 0.001 | |||
| Us-gaap_interestexpense | 3.153 | |||
| Us-gaap_incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest | -3.354 | |||
| Us-gaap_incometaxexpensebenefit | -0.043 | |||
| Net loss | -3.311 | |||
| Us-gaap_netincomelossavailabletocommonstockholdersbasic | -3.311 | |||
| Basic eps | -0.06 | |||
| Basic average shares | 54,383,604 | |||
null (ALIM)
null (ALIM)